Market Tracker

09/23 5:16pm ET

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

3.19
Delayed Data
As of Sep 23
 +0.05 / +1.59%
Today’s Change
2.28
Today|||52-Week Range
8.95
-31.25%
Year-to-Date
No recent news for Anthera Pharmaceuticals Inc.

Today’s Trading

Previous close3.14
Today’s open3.11
Day’s range3.06 - 3.23
Volume428,586
Average volume (3 months)494,665
Market cap$132.2M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+27.21%
Earnings growth (this year)-36.45%
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales51.91
Price/Book3.22

Competitors

 Today’s
change
Today’s
% change
ECYTEndocyte Inc-0.01-0.32%
CORICorium International...0.000.00%
NVLSNivalis Therapeutics...-0.28-3.23%
ADHDAlcobra Ltd-0.05-1.06%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateOctober 19, 2016
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$3.2M
Annual profit (last year)-$35.2M
Net profit margin-1,105.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Paul F. Truex
President &
Chief Operating Officer
John Craig Thompson
Corporate headquarters
Hayward, California

Forecasts